Journey Medical (DERM) Revenue (2020 - 2026)

Journey Medical's Revenue history runs 7 years deep, the most recent figure standing at $15.9 million for Q1 2026.

• Quarterly Revenue rose 21.17% year-over-year to $15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.0 million (up 15.91% YoY) and the FY2025 annual result came in at $61.9 million, up 12.2% from the prior year.
• Revenue was $15.9 million for Q1 2026 at Journey Medical, down from $16.1 million in the prior quarter.
• Across five years, Revenue topped out at $34.5 million in Q3 2023 and bottomed at $12.2 million in Q1 2023.
• A 5-year average of $16.6 million and a median of $15.9 million in 2022 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue surged 114.31% — and 2024, when it sank 57.64%.
• Journey Medical's Revenue stood at $15.9 million in 2022, then decreased by 4.17% to $15.3 million in 2023, then fell by 17.28% to $12.6 million in 2024, then rose by 27.41% to $16.1 million in 2025, then fell by 0.98% to $15.9 million in 2026.
• Business Quant data shows DERM's Revenue at $15.9 million in Q1 2026, $16.1 million in Q4 2025, and $17.0 million in Q3 2025.